Key result
Sulfated polysaccharides dosed for ~75% thrombus inhibition show varying effectiveness across different thrombogenic stimuli.
Why the study?
Does the antithrombotic effectiveness of heparin, pentosan polysulfate, and dermatan sulfate vary depending on the thrombogenic stimulus in a rabbit model?
Does the antithrombotic effectiveness of heparin, pentosan polysulfate, and dermatan sulfate vary depending on the thrombogenic stimulus in a rabbit model?
The antithrombotic efficacy of specific sulfated polysaccharides varies depending on the specific stimulus initiating thrombus formation.
Answers are grounded in this paper and cite their sources.
Stimulus-specific antithrombotic effects seen in rabbits; hypothesis-generating and should not yet guide clinical anticoagulant selection.
To test the possibility that different doses of heparin or other sulfated polysaccharides are required to inhibit thrombosis initiated by different stimuli, we compared the effects of heparin (HEP), pentosan polysulfate (SP54) and dermatan sulfate (DS) on the inhibition of thrombus formation induced by either I) tissue thromboplastin; II) thrombin; or III) factor Xa. Inhibition of thrombus formation induced by the stimuli was measured in a rabbit jugular vein hypercoagulation/stasis model. First, we determined the minimum dose of each sulfated polysaccharide which inhibited tissue thromboplastin-induced thrombus formation by approximately 75%, and then compared the relative effectiveness of this dose to prevent thrombus formation initiated with the other two stimuli. HEP and SP54 were less effective when thrombin was the thrombogenic stimulus, while DS was more effective. HEP was the most effective agent when factor Xa was the stimulus. We conclude that the antithrombotic effectiveness of a given dose of a sulfated polysaccharide may vary depending on the stimulus which initiates thrombus formation.
No takes yet. Share an insight, caveat, or question.
Ryn-McKenna et al. (1989) studied Thrombus formation. Sulfated polysaccharides (heparin, pentosan polysulfate, dermatan sulfate) was evaluated on Inhibition of thrombus formation. Sulfated polysaccharides dosed to inhibit thromboplastin-induced thrombus by ~75% showed varying effectiveness depending on whether the stimulus was thrombin, factor Xa, or tissue thromboplastin.
Synapse has enriched 10 related papers. Consider them for comparative context: